Biology and applications of CRISPR–Cas12 and transposon-associated homologs – Nature Biotechnology
Makarova, K. S. et al. Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants. Nat. Rev. Microbiol. 18, 67–83 (2020).
Google Scholar
van der Oost, J. in CRISPR: Biology and Applications (eds Barrangou, R., Sontheimer, E. J. & Marraffini, L. A.) Ch. 3 (Wiley, 2022).
van der Oost, J., Jore, M. M., Westra, E. R., Lundgren, M. & Brouns, S. J. CRISPR-based adaptive and heritable immunity in prokaryotes. Trends Biochem. Sci. 34, 401–407 (2009).
Google Scholar
Mohanraju, P. et al. Diverse evolutionary roots and mechanistic variations of the CRISPR–Cas systems. Science 353, aad5147 (2016).
Google Scholar
Jinek, M. et al. RNA-programmed genome editing in human cells. eLife 2, e00471 (2013).
Google Scholar
Jiang, W., Bikard, D., Cox, D., Zhang, F. & Marraffini, L. A. RNA-guided editing of bacterial genomes using CRISPR–Cas systems. Nat. Biotechnol. 31, 233–239 (2013).
Google Scholar
Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR–Cas system. Cell 163, 759–771 (2015).
Google Scholar
Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709–1712 (2007).
Google Scholar
Deveau, H. et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol. 190, 1390–1400 (2008).
Google Scholar
Garneau, J. E. et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468, 67–71 (2010).
Google Scholar
Deltcheva, E. et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471, 602–607 (2011).
Google Scholar
Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).
Google Scholar
Gasiunas, G., Barrangou, R., Horvath, P. & Siksnys, V. Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl Acad. Sci. USA 109, E2579–E2586 (2012).
Google Scholar
Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).
Google Scholar
Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).
Google Scholar
Cho, S. W., Kim, S., Kim, J. M. & Kim, J. S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 31, 230–232 (2013).
Google Scholar
Gasiunas, G. et al. A catalogue of biochemically diverse CRISPR–Cas9 orthologs. Nat. Commun. 11, 5512 (2020).
Google Scholar
Aliaga Goltsman, D. S. et al. Compact Cas9d and HEARO enzymes for genome editing discovered from uncultivated microbes. Nat. Commun. 13, 7602 (2022).
Google Scholar
Altae-Tran, H. et al. The widespread IS200/IS605 transposon family encodes diverse programmable RNA-guided endonucleases. Science 374, 57–65 (2021).
Google Scholar
Makarova, K. S. & Koonin, E. V. Annotation and classification of CRISPR–Cas systems. Methods Mol. Biol. 1311, 47–75 (2015).
Google Scholar
Teng, F. et al. Repurposing CRISPR–Cas12b for mammalian genome engineering. Cell Discov. 4, 63 (2018).
Google Scholar
Wu, W. Y. et al. The miniature CRISPR–Cas12m effector binds DNA to block transcription. Mol. Cell 82, 4487–4502 (2022).
Google Scholar
Koonin, E. V., Makarova, K. S. & Zhang, F. Diversity, classification and evolution of CRISPR–Cas systems. Curr. Opin. Microbiol. 37, 67–78 (2017).
Google Scholar
Altae-Tran, H. et al. Diversity, evolution, and classification of the RNA-guided nucleases TnpB and Cas12. Proc. Natl Acad. Sci. USA 120, e2308224120 (2023).
Google Scholar
Capdeville, N., Schindele, P. & Puchta, H. Getting better all the time—recent progress in the development of CRISPR/Cas-based tools for plant genome engineering. Curr. Opin. Biotechnol. 79, 102854 (2023).
Google Scholar
Huang, C. H., Lee, K. C. & Doudna, J. A. Applications of CRISPR–Cas enzymes in cancer therapeutics and detection. Trends Cancer 4, 499–512 (2018).
Google Scholar
Donohoue, P. D., Barrangou, R. & May, A. P. Advances in industrial biotechnology using CRISPR–Cas systems. Trends Biotechnol. 36, 134–146 (2018).
Google Scholar
Kersulyte, D., Mukhopadhyay, A. K., Shirai, M., Nakazawa, T. & Berg, D. E. Functional organization and insertion specificity of IS607, a chimeric element of Helicobacter pylori. J. Bacteriol. 182, 5300–5308 (2000).
Google Scholar
Karvelis, T. et al. Transposon-associated TnpB is a programmable RNA-guided DNA endonuclease. Nature 599, 692–696 (2021).
Google Scholar
Ton-Hoang, B. et al. Single-stranded DNA transposition is coupled to host replication. Cell 142, 398–408 (2010).
Google Scholar
Meers, C. et al. Transposon-encoded nucleases use guide RNAs to promote their selfish spread. Nature 622, 863–871 (2023).
Google Scholar
Saito, M. et al. Fanzor is a eukaryotic programmable RNA-guided endonuclease. Nature 620, 660–668 (2023).
Google Scholar
Jiang, K. et al. Programmable RNA-guided DNA endonucleases are widespread in eukaryotes and their viruses. Sci. Adv. 9, eadk0171 (2023).
Google Scholar
Aravind, L., Makarova, K. S. & Koonin, E. V. Holliday junction resolvases and related nucleases: identification of new families, phyletic distribution and evolutionary trajectories. Nucleic Acids Res. 28, 3417–3432 (2000).
Google Scholar
Majorek, K. A. et al. The RNase H-like superfamily: new members, comparative structural analysis and evolutionary classification. Nucleic Acids Res. 42, 4160–4179 (2014).
Google Scholar
Xiang, G. et al. Evolutionary mining and functional characterization of TnpB nucleases identify efficient miniature genome editors. Nat. Biotechnol. 42, 745–757 (2024).
Google Scholar
Makarova, K. S., Wolf, Y. I. & Koonin, E. V. in CRISPR: Biology and Applications (eds Barrangou, R., Sontheimer, E. J. & Marraffini, L. A.) Ch. 2 (Wiley, 2022).
Shmakov, S. et al. Diversity and evolution of class 2 CRISPR–Cas systems. Nat. Rev. Microbiol. 15, 169–182 (2017).
Google Scholar
Nakagawa, R. et al. Cryo-EM structure of the transposon-associated TnpB enzyme. Nature 616, 390–397 (2023).
Google Scholar
Sasnauskas, G. et al. TnpB structure reveals minimal functional core of Cas12 nuclease family. Nature 616, 384–389 (2023).
Google Scholar
Swarts, D. C., van der Oost, J. & Jinek, M. Structural basis for guide RNA processing and seed-dependent DNA targeting by CRISPR–Cas12a. Mol. Cell 66, 221–233 (2017).
Google Scholar
Huang, C. J., Adler, B. A. & Doudna, J. A. A naturally DNase-free CRISPR–Cas12c enzyme silences gene expression. Mol. Cell 82, 2148–2160 (2022).
Google Scholar
Wiegand, T. et al. TnpB homologues exapted from transposons are RNA-guided transcription factors. Nature 631, 439–448 (2024).
Google Scholar
Turchiano, G. et al. Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-seq. Cell Stem Cell 28, 1136–1147 (2021).
Google Scholar
Takeda, S. N. et al. Structure of the miniature type V-F CRISPR–Cas effector enzyme. Mol. Cell 81, 558–570 (2021).
Google Scholar
Xiao, R., Li, Z., Wang, S., Han, R. & Chang, L. Structural basis for substrate recognition and cleavage by the dimerization-dependent CRISPR–Cas12f nuclease. Nucleic Acids Res. 49, 4120–4128 (2021).
Google Scholar
Nety, S. P. et al. The transposon-encoded protein TnpB processes its own mRNA into ωRNA for guided nuclease activity. CRISPR J. 6, 232–242 (2023).
Google Scholar
Shmakov, S. et al. Discovery and functional characterization of diverse class 2 CRISPR–Cas systems. Mol. Cell 60, 385–397 (2015).
Google Scholar
Kurihara, N. et al. Structure of the type V-C CRISPR–Cas effector enzyme. Mol. Cell 82, 1865–1877 (2022).
Google Scholar
Zhang, B. et al. Structural insights into target DNA recognition and cleavage by the CRISPR–Cas12c1 system. Nucleic Acids Res. 50, 11820–11833 (2022).
Google Scholar
Li, Z., Zhang, H., Xiao, R., Han, R. & Chang, L. Cryo-EM structure of the RNA-guided ribonuclease Cas12g. Nat. Chem. Biol. 17, 387–393 (2021).
Google Scholar
Strecker, J. et al. RNA-guided DNA insertion with CRISPR-associated transposases. Science 365, 48–53 (2019).
Google Scholar
Sun, A. et al. The compact Casπ (Cas12l) ‘bracelet’ provides a unique structural platform for DNA manipulation. Cell Res. 33, 229–244 (2023).
Google Scholar
Harrington, L. B. et al. A scoutRNA is required for some type V CRISPR–Cas systems. Mol. Cell 79, 416–424 (2020).
Google Scholar
Liu, J. J. et al. CasX enzymes comprise a distinct family of RNA-guided genome editors. Nature 566, 218–223 (2019).
Google Scholar
Liao, C. & Beisel, C. L. The tracrRNA in CRISPR biology and technologies. Annu. Rev. Genet. 55, 161–181 (2021).
Google Scholar
Fonfara, I., Richter, H., Bratovič, M., Le Rhun, A. & Charpentier, E. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 532, 517–521 (2016).
Google Scholar
Zetsche, B. et al. Multiplex gene editing by CRISPR–Cpf1 using a single crRNA array. Nat. Biotechnol. 35, 31–34 (2017).
Google Scholar
Yan, W. X. et al. Functionally diverse type V CRISPR–Cas systems. Science 363, 88–91 (2019).
Google Scholar
Pausch, P. et al. CRISPR–CasΦ from huge phages is a hypercompact genome editor. Science 369, 333–337 (2020).
Google Scholar
Al-Shayeb, B. et al. Diverse virus-encoded CRISPR–Cas systems include streamlined genome editors. Cell 185, 4574–4586 (2022).
Google Scholar
Zhang, H., Li, Z., Xiao, R. & Chang, L. Mechanisms for target recognition and cleavage by the Cas12i RNA-guided endonuclease. Nat. Struct. Mol. Biol. 27, 1069–1076 (2020).
Google Scholar
Karvelis, T. et al. PAM recognition by miniature CRISPR–Cas12f nucleases triggers programmable double-stranded DNA target cleavage. Nucleic Acids Res. 48, 5016–5023 (2020).
Google Scholar
Bravo, J. P. K. et al. RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2. Nature 613, 582–587 (2023).
Google Scholar
Abudayyeh, O. O. et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353, aaf5573 (2016).
Google Scholar
Abudayyeh, O. O. et al. RNA targeting with CRISPR–Cas13. Nature 550, 280–284 (2017).
Google Scholar
Gao, P., Yang, H., Rajashankar, K. R., Huang, Z. & Patel, D. J. Type V CRISPR–Cas Cpf1 endonuclease employs a unique mechanism for crRNA-mediated target DNA recognition. Cell Res. 26, 901–913 (2016).
Google Scholar
Yamano, T. et al. Structural basis for the canonical and non-canonical PAM recognition by CRISPR–Cpf1. Mol. Cell 67, 633–645 (2017).
Google Scholar
Xiao, R. et al. Structural basis of target DNA recognition by CRISPR–Cas12k for RNA-guided DNA transposition. Mol. Cell 81, 4457–4466 (2021).
Google Scholar
Swarts, D. C. et al. The evolutionary journey of Argonaute proteins. Nat. Struct. Mol. Biol. 21, 743–753 (2014).
Google Scholar
Hegge, J. W., Swarts, D. C. & van der Oost, J. Prokaryotic Argonaute proteins: novel genome-editing tools? Nat. Rev. Microbiol. 16, 5–11 (2018).
Google Scholar
Swarts, D. C. Making the cut(s): how Cas12a cleaves target and non-target DNA. Biochem. Soc. Trans. 47, 1499–1510 (2019).
Google Scholar
Selkova, P. et al. Position of Deltaproteobacteria Cas12e nuclease cleavage sites depends on spacer length of guide RNA. RNA Biol. 17, 1472–1479 (2020).
Google Scholar
Lei, C. et al. The CCTL (Cpf1-assisted cutting and Taq DNA ligase-assisted ligation) method for efficient editing of large DNA constructs in vitro. Nucleic Acids Res. 45, e74 (2017).
Google Scholar
Strecker, J. et al. Engineering of CRISPR–Cas12b for human genome editing. Nat. Commun. 10, 212 (2019).
Google Scholar
Huang, X. et al. Structural basis for two metal-ion catalysis of DNA cleavage by Cas12i2. Nat. Commun. 11, 5241 (2020).
Google Scholar
Chen, J. S. et al. CRISPR–Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science 360, 436–439 (2018).
Google Scholar
Harrington, L. B. et al. Programmed DNA destruction by miniature CRISPR–Cas14 enzymes. Science 362, 839–842 (2018).
Google Scholar
Li, L. et al. HOLMESv2: a CRISPR–Cas12b-assisted platform for nucleic acid detection and DNA methylation quantitation. ACS Synth. Biol. 8, 2228–2237 (2019).
Google Scholar
Swarts, D. C. & Jinek, M. Mechanistic insights into the cis– and trans-acting DNase activities of Cas12a. Mol. Cell 73, 589–600 (2019).
Google Scholar
Marino, N. D., Pinilla-Redondo, R. & Bondy-Denomy, J. CRISPR–Cas12a targeting of ssDNA plays no detectable role in immunity. Nucleic Acids Res. 50, 6414–6422 (2022).
Google Scholar
Dmytrenko, O. et al. Cas12a2 elicits abortive infection through RNA-triggered destruction of dsDNA. Nature 613, 588–594 (2023).
Google Scholar
Wendt, K. E., Ungerer, J., Cobb, R. E., Zhao, H. & Pakrasi, H. B. CRISPR/Cas9 mediated targeted mutagenesis of the fast growing cyanobacterium Synechococcus elongatus UTEX 2973. Micro. Cell Fact. 15, 115 (2016).
Google Scholar
Jiang, Y. et al. CRISPR–Cpf1 assisted genome editing of Corynebacterium glutamicum. Nat. Commun. 8, 15179 (2017).
Google Scholar
Zhang, Y. et al. Expanding the scope of plant genome engineering with Cas12a orthologs and highly multiplexable editing systems. Nat. Commun. 12, 1944 (2021).
Google Scholar
Naduthodi, M. I. S. et al. CRISPR–Cas ribonucleoprotein mediated homology-directed repair for efficient targeted genome editing in microalgae Nannochloropsis oceanica IMET1. Biotechnol. Biofuels 12, 66 (2019).
Google Scholar
Wrighton, P. J. et al. Chemically modified AsCas12a guide RNAs improve lipid nanoparticle–mediated in vivo gene editing in different tissues. Presented at The American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, May 7–11 (2024).
Sousa, P. et al. Preclinical development of EDIT301, an autologous cell therapy comprising AsCas12a-RNP modified mobilized peripheral blood-CD34+ cells for the potential treatment of transfusion dependent β thalassemia. Blood 138, 1858 (2021).
Google Scholar
Stein, R. A. Molecular scissors are making the cut…in clinical trials: treatments based on various genome editing technologies—CRISPR, TALEN, ZFN, and meganuclease technologies—are starting to reach patients. Genet. Eng. Biotechnol. N. 43, 36–38 (2023).
Google Scholar
Hino, T. et al. An AsCas12f-based compact genome-editing tool derived by deep mutational scanning and structural analysis. Cell 186, 4920–4935 (2023).
Google Scholar
Bigelyte, G. et al. Miniature type V-F CRISPR–Cas nucleases enable targeted DNA modification in cells. Nat. Commun. 12, 6191 (2021).
Google Scholar
Kim, D. Y. et al. Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus. Nat. Biotechnol. 40, 94–102 (2022).
Google Scholar
Wu, Z. et al. Programmed genome editing by a miniature CRISPR–Cas12f nuclease. Nat. Chem. Biol. 17, 1132–1138 (2021).
Google Scholar
Xu, X. et al. Engineered miniature CRISPR–Cas system for mammalian genome regulation and editing. Mol. Cell 81, 4333–4345 (2021).
Google Scholar
Chen, W. et al. Cas12n nucleases, early evolutionary intermediates of type V CRISPR, comprise a distinct family of miniature genome editors. Mol. Cell 83, 2768–2780 (2023).
Google Scholar
Wang, Y. et al. Guide RNA engineering enables efficient CRISPR editing with a miniature Syntrophomonas palmitatica Cas12f1 nuclease. Cell Rep. 40, 111418 (2022).
Google Scholar
Tou, C. J., Orr, B. & Kleinstiver, B. P. Precise cut-and-paste DNA insertion using engineered type V-K CRISPR-associated transposases. Nat. Biotechnol. 41, 968–979 (2023).
Google Scholar
Zhang, H. et al. An engineered xCas12i with high activity, high specificity, and broad PAM range. Protein Cell 14, 538–543 (2023).
Google Scholar
Chen, Y. et al. Synergistic engineering of CRISPR–Cas nucleases enables robust mammalian genome editing. Innovation 3, 100264 (2022).
Google Scholar
Slaymaker, I. M. et al. Rationally engineered Cas9 nucleases with improved specificity. Science 351, 84–88 (2016).
Google Scholar
Kleinstiver, B. P. et al. High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529, 490–495 (2016).
Google Scholar
Huang, H. et al. Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity. BMC Biol. 20, 91 (2022).
Google Scholar
Kleinstiver, B. P. et al. Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat. Biotechnol. 37, 276–282 (2019).
Google Scholar
Gao, L. et al. Engineered Cpf1 variants with altered PAM specificities. Nat. Biotechnol. 35, 789–792 (2017).
Google Scholar
Tóth, E. et al. Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases. Nucleic Acids Res. 48, 3722–3733 (2020).
Google Scholar
Kim, D. Y. et al. Hypercompact adenine base editors based on transposase B guided by engineered RNA. Nat. Chem. Biol. 18, 1005–1013 (2022).
Google Scholar
Ma, E. et al. Improved genome editing by an engineered CRISPR–Cas12a. Nucleic Acids Res. 50, 12689–12701 (2022).
Google Scholar
Wu, T. et al. An engineered hypercompact CRISPR–Cas12f system with boosted gene-editing activity. Nat. Chem. Biol. 19, 1384–1393 (2023).
Google Scholar
Li, Z. et al. Engineering a transposon-associated TnpB–ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse model. Nat. Commun. 15, 831 (2024).
Google Scholar
Marquart, K. F. et al. Effective genome editing with an enhanced ISDra2 TnpB system and deep learning-predicted ωRNAs. Nat. Methods https://doi.org/10.1038/s41592-024-02418-z (2024).
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016).
Google Scholar
Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824–844 (2020).
Google Scholar
Gaudelli, N. M. et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 551, 464–471 (2017).
Google Scholar
Parameshwaran, H. P. et al. The bridge helix of Cas12a imparts selectivity in cis-DNA cleavage and regulates trans-DNA cleavage. FEBS Lett. 595, 892–912 (2021).
Google Scholar
Yamano, T. et al. Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 165, 949–962 (2016).
Google Scholar
Li, X. et al. Base editing with a Cpf1–cytidine deaminase fusion. Nat. Biotechnol. 36, 324–327 (2018).
Google Scholar
Wang, X. et al. Cas12a base editors induce efficient and specific editing with low DNA damage response. Cell Rep. 31, 107723 (2020).
Google Scholar
Certo, M. T. et al. Tracking genome engineering outcome at individual DNA breakpoints. Nat. Methods 8, 671–676 (2011).
Google Scholar
Wu, W. Y., Lebbink, J. H. G., Kanaar, R., Geijsen, N. & van der Oost, J. Genome editing by natural and engineered CRISPR-associated nucleases. Nat. Chem. Biol. 14, 642–651 (2018).
Google Scholar
Anzalone, A. V. et al. Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. Nat. Biotechnol. 40, 731–740 (2022).
Google Scholar
Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149–157 (2019).
Google Scholar
Kim, Y. B. et al. A novel mechanistic framework for precise sequence replacement using reverse transcriptase and diverse CRISPR–Cas systems. Preprint at bioRxiv https://doi.org/10.1101/2022.12.13.520319 (2022).
Liang, R. et al. Prime editing using CRISPR–Cas12a and circular RNAs in human cells. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-02095-x (2024).
Liu, B. et al. A split prime editor with untethered reverse transcriptase and circular RNA template. Nat. Biotechnol. 40, 1388–1393 (2022).
Google Scholar
Meliawati, M., Schilling, C. & Schmid, J. Recent advances of Cas12a applications in bacteria. Appl. Microbiol. Biotechnol. 105, 2981–2990 (2021).
Google Scholar
Wu, Y. et al. CAMERS-B: CRISPR/Cpf1 assisted multiple-genes editing and regulation system for Bacillus subtilis. Biotechnol. Bioeng. 117, 1817–1825 (2020).
Google Scholar
Schilling, C., Koffas, M. A. G., Sieber, V. & Schmid, J. Novel prokaryotic CRISPR–Cas12a-based tool for programmable transcriptional activation and repression. ACS Synth. Biol. 9, 3353–3363 (2020).
Google Scholar
Tak, Y. E. et al. Inducible and multiplex gene regulation using CRISPR–Cpf1-based transcription factors. Nat. Methods 14, 1163–1166 (2017).
Google Scholar
Kong, X. et al. Engineered CRISPR–OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing. Nat. Commun. 14, 2046 (2023).
Google Scholar
Liang, M. et al. Activating cryptic biosynthetic gene cluster through a CRISPR–Cas12a-mediated direct cloning approach. Nucleic Acids Res. 50, 3581–3592 (2022).
Google Scholar
Enghiad, B. et al. Cas12a-assisted precise targeted cloning using in vivo Cre–lox recombination. Nat. Commun. 12, 1171 (2021).
Google Scholar
Broughton, J. P. et al. CRISPR–Cas12-based detection of SARS-CoV-2. Nat. Biotechnol. 38, 870–874 (2020).
Google Scholar
Li, S. Y. et al. CRISPR–Cas12a-assisted nucleic acid detection. Cell Discov. 4, 20 (2018).
Google Scholar
Li, S. Y. et al. CRISPR–Cas12a has both cis– and trans-cleavage activities on single-stranded DNA. Cell Res. 28, 491–493 (2018).
Google Scholar
Kaminski, M. M., Abudayyeh, O. O., Gootenberg, J. S., Zhang, F. & Collins, J. J. CRISPR-based diagnostics. Nat. Biomed. Eng. 5, 643–656 (2021).
Google Scholar
Teng, F. et al. CDetection: CRISPR–Cas12b-based DNA detection with sub-attomolar sensitivity and single-base specificity. Genome Biol. 20, 132 (2019).
Google Scholar
Wang, Z. & Zhong, C. Cas12c-DETECTOR: a specific and sensitive Cas12c-based DNA detection platform. Int. J. Biol. Macromol. 193, 441–449 (2021).
Google Scholar
Rananaware, S. R. et al. Programmable RNA detection with CRISPR–Cas12a. Nat. Commun. 14, 5409 (2023).
Google Scholar
Zhou, S. et al. CRISPR/Cas12a-drived fluorescent and electrochemical signal-off/on dual-mode biosensors for ultrasensitive detection of EGFR 19del mutation. Sensor Actuat. B Chem. 392, 134034 (2023).
Google Scholar
Klompe, S. E., Vo, P. L. H., Halpin-Healy, T. S. & Sternberg, S. H. Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration. Nature 571, 219–225 (2019).
Google Scholar
Peters, J. E., Makarova, K. S., Shmakov, S. & Koonin, E. V. Recruitment of CRISPR–Cas systems by Tn7-like transposons. Proc. Natl Acad. Sci. USA 114, E7358–E7366 (2017).
Google Scholar
Park, J. U. et al. Structures of the holo CRISPR RNA-guided transposon integration complex. Nature 613, 775–782 (2023).
Google Scholar
Querques, I., Schmitz, M., Oberli, S., Chanez, C. & Jinek, M. Target site selection and remodelling by type V CRISPR-transposon systems. Nature 599, 497–502 (2021).
Google Scholar
Altae-Tran, H. et al. Uncovering the functional diversity of rare CRISPR–Cas systems with deep terascale clustering. Science 382, eadi1910 (2023).
Google Scholar
Durrant, M. G. et al. Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genome. Nat. Biotechnol. 41, 488–499 (2023).
Google Scholar
Chen, F. et al. Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors. Commun. Biol. 5, 1163 (2022).
Google Scholar
Yarnall, M. T. N. et al. Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases. Nat. Biotechnol. 41, 500–512 (2023).
Google Scholar
Vialetto, E. et al. Systematic interrogation of CRISPR antimicrobials in Klebsiella pneumoniae reveals nuclease-, guide- and strain-dependent features influencing antimicrobial activity. Nucleic Acids Res. 52, 6079–6091 (2024).
Google Scholar
Ding, X. et al. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR–Cas12a assay. Nat. Commun. 11, 4711 (2020).
Google Scholar
Wang, J. Y. & Doudna, J. A. CRISPR technology: a decade of genome editing is only the beginning. Science 379, eadd8643 (2023).
Google Scholar
Xin, C. et al. Comprehensive assessment of miniature CRISPR–Cas12f nucleases for gene disruption. Nat. Commun. 13, 5623 (2022).
Google Scholar
Li, S. et al. Payload distribution and capacity of mRNA lipid nanoparticles. Nat. Commun. 13, 5561 (2022).
Google Scholar
Villiger, L. et al. CRISPR technologies for genome, epigenome and transcriptome editing. Nat. Rev. Mol. Cell Biol. 25, 464–487 (2024).
Google Scholar
Wong, C. UK first to approve CRISPR treatment for diseases: what you need to know. Nature 623, 676–677 (2023).
Google Scholar
Longhurst, H. J. et al. CRISPR–Cas9 in vivo gene editing of KLKB1 for hereditary angioedema. N. Engl. J. Med. 390, 432–441 (2024).
Google Scholar
O’Leary, K. Gene-editing breakthrough for a rare hereditary disorder. Nat. Med. https://doi.org/10.1038/d41591-024-00008-2 (2024).
Chew, W. L. Immunity to CRISPR Cas9 and Cas12a therapeutics. Wiley Interdiscip. Rev. Syst. Biol. Med. 10, e1408 (2018).
Wagner, D. L. et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat. Med. 25, 242–248 (2019).
Google Scholar
Ferdosi, S. R. et al. Multifunctional CRISPR–Cas9 with engineered immunosilenced human T cell epitopes. Nat. Commun. 10, 1842 (2019).
Google Scholar
Burstein, D. et al. New CRISPR–Cas systems from uncultivated microbes. Nature 542, 237–241 (2017).
Google Scholar
Yang, H. & Patel, D. J. CasX: a new and small CRISPR gene-editing protein. Cell Res. 29, 345–346 (2019).
Google Scholar
Carabias, A. et al. Structure of the mini-RNA-guided endonuclease CRISPR–Cas12j3. Nat. Commun. 12, 4476 (2021).
Google Scholar
Park, J. U. et al. Structural basis for target site selection in RNA-guided DNA transposition systems. Science 373, 768–774 (2021).
Google Scholar
Urbaitis, T. et al. A new family of CRISPR-type V nucleases with C-rich PAM recognition. EMBO Rep. 23, e55481 (2022).
Google Scholar
